Optical Coherence Tomography Angiography Biomarkers as Indicators of Cardiovascular Disease
Rebecca L. Kellner,Alon Harris,Lauren Ciulla,Giovanna Guidoboni,Alice Verticchio Vercellin,Francesco Oddone,Carmela Carnevale,Mohamed Zaid,Gal Antman,Jeffrey T. Kuvin,Brent Siesky
DOI: https://doi.org/10.3390/jcm13030829
IF: 3.9
2024-02-01
Journal of Clinical Medicine
Abstract:Alterations in microvasculature represent some of the earliest pathological processes across a wide variety of human diseases. In many organs, however, inaccessibility and difficulty in directly imaging tissues prevent the assessment of microvascular changes, thereby significantly limiting their translation into improved patient care. The eye provides a unique solution by allowing for the non-invasive and direct visualization and quantification of many aspects of the human microvasculature, including biomarkers for structure, function, hemodynamics, and metabolism. Optical coherence tomography angiography (OCTA) studies have specifically identified reduced capillary densities at the level of the retina in several eye diseases including glaucoma. This narrative review examines the published data related to OCTA-assessed microvasculature biomarkers and major systemic cardiovascular disease. While loss of capillaries is being established in various ocular disease, pilot data suggest that changes in the retinal microvasculature, especially within the macula, may also reflect small vessel damage occurring in other organs resulting from cardiovascular disease. Current evidence suggests retinal microvascular biomarkers as potential indicators of major systemic cardiovascular diseases, including systemic arterial hypertension, atherosclerotic disease, and congestive heart failure.
medicine, general & internal